29344 Federal Register / Vol. 66, No. 104 / Wednesday, May 30, 2001 / Notices

INTERNATIONAL TRADE

COMMISSION

[Investigation No. 731–TA–894 (Final)]

Certain Ammonium Nitrate From

Ukraine

AGENCY: United States International

Trade Commission.

ACTION: Revised schedule for the subject

investigation.

EFFECTIVE DATE: May 22, 2001.

FOR FURTHER INFORMATION CONTACT: Gail

Burns (202–205–2501), Office of

Investigations, U.S. International Trade

Commission, 500 E Street SW.,

Washington, DC 20436. Hearingimpaired persons can obtain

information on this matter by contacting

the Commission’s TDD terminal on 202–

205–1810. Persons with mobility

impairments who will need special

assistance in gaining access to the

Commission should contact the Office

of the Secretary at 202–205–2000.

General information concerning the

Commission may also be obtained by

accessing its internet server (http://

www.usitc.gov). The public record for

this investigation may be viewed on the

Commission’s electronic docket (EDIS–

ON–LINE) at http://dockets.usitc.gov/

eol/public.

SUPPLEMENTARY INFORMATION: On March

7, 2001, the Commission established a

schedule for the conduct of the final

phase of the subject investigation (66 FR

14933, March 14, 2001). The

Department of Commerce notified the

Commission on May 17, 2001, that the

date for its final determination in the

investigation was extended from June

18, 2001 to July 18, 2001. The

Commission, therefore, is revising its

schedule to conform with Commerce’s

new schedule.

The Commission’s new schedule for

the investigation is as follows: requests

to appear at the hearing must be filed

with the Secretary to the Commission

not later than July 16, 2001; the

prehearing conference will be held at

the U.S. International Trade

Commission Building at 9:30 a.m. on

July 19, 2001; the prehearing staff report

will be placed in the nonpublic record

on July 11, 2001; the deadline for filing

prehearing briefs is July 18, 2001; the

hearing will be held at the U.S.

International Trade Commission

Building at 9:30 a.m. on July 24, 2001;

the deadline for filing posthearing briefs

is July 31, 2001; the Commission will

make its final release of information on

August 16, 2001; and final party

comments are due on August 20, 2001.

For further information concerning

this investigation see the Commission’s

notice cited above and the

Commission’s Rules of Practice and

Procedure, part 201, subparts A through

E (19 CFR part 201), and part 207,

subparts A and C (19 CFR part 207).

Authority: This investigation is being

conducted under authority of title VII of the

Tariff Act of 1930; this notice is published

pursuant to section 207.21 of the

Commission’s rules.

By order of the Commission.

Issued: May 23, 2001.

Donna R. Koehnke,

Secretary.

[FR Doc. 01–13467 Filed 5–29–01; 8:45 am]

BILLING CODE 7020–02–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to § 1301.33(a) of Title 21 of

the Code of Federal Regulations (CFR),

this is notice that on December 27, 2000,

Mallinckrodt, Inc., Mallinckrodt &

Second Streets, St. Louis, Missouri

63147, made application by renewal to

the Drug Enforcement Administration

(DEA) for registration as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Tetrahydrocannabinols (7370) ..... I

Dihydromorphine (9145) ............... I

Amphetamine (1100) .................... II

Methylphenidate (1724) ................ II

Cocaine (9041) ............................. II

Codeine (9050) ............................. II

Diprenorphine (9058) ................... II

Etorphine Hydrochloride (9059) ... II

Dihydrocodeine (9120) ................. II

Oxycodone (9143) ........................ II

Hydromorphone (9150) ................ II

Diphenoxylate (9170) ................... II

Hydrocodone (9193) ..................... II

Levorphanol (9220) ...................... II

Meperidine (9230) ........................ II

Methadone (9250) ........................ II

Methadone-intermediate (9254) ... II

Dextropopoxyphene, bulk (nondosage forms) (9273).II

Morphine (9300) ........................... II

Thebaine (9333) ........................... II

Opium extracts (9610) .................. II

Opium fluid extract (9620) ............ II

Opium tincture (9630) .................. II

Opium powdered (9639) .............. II

Opium granulated (9640) ............. II

Levo-alphacetylmethadol (9648) .. II

Oxymorphone (9652) ................... II

Noroxymorphone (9668) .............. II

Alfentanil (9737) ........................... II

Sufentanil (9740) .......................... II

Fentanyl (9801) ............................ II

The firm plans to manufacture the

controlled substances for distribution as

bulk products to its customers.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substances

may file comments or objections to the

issuance of the proposed registration.

Any such comments or objections

may be addressed, in quintuplicate, to

the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, DC 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than July 30,

2001.

Dated: May 14, 2001.

Laura M. Nagel,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 01–13446 Filed 5–29–01; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Application

AGENCY: Pursuant to section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with

§ 1301.34 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on March 5, 2001,

Mallinckrodt, Inc., Mallinckrodt &

Second Streets, St. Louis, Missouri

63147, made application by renewal to

the Drug Enforcement Administration to

be registered as an importer of the basic

classes of controlled substances listed

below:

Drug Schedule

Phenylacetone (8501) .................. II

Coca Leaves (9040) ..................... II

Opium, raw (9600) ....................... II

Opium poppy (9650) .................... II

Poppy Straw Concentrate (9670) II

The firm plans to import the listed

controlled substances to bulk

manufacture controlled substances.